HIV Clinical Trial
Official title:
Community-based Interventions to Increase HIV Testing and HIV Care Utilization
| NCT number | NCT01867177 |
| Other study ID # | KP2012 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | June 2013 |
| Est. completion date | December 2017 |
| Verified date | July 2018 |
| Source | Kaiser Permanente |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to conduct a cross-site evaluation of the Kaiser Permanente's
Community-based Interventions to Increase HIV Testing and HIV Care Utilization Program,
designed to support community-based interventions to reduce the number of new HIV cases and
to increase HIV care acquisition and maintenance in minority communities disproportionately
affected by the HIV epidemic. This effort builds on the President's National Strategy for HIV
Prevention and recent research documenting the importance and efficacy of "test and treat"
and "treatment as prevention" approaches. Hence, goals of this important and novel work will
focus on the following objectives:
1. identification of HIV infection among recently infected adolescents and adults
2. improved access to HIV care, particularly among newly diagnosed adolescents and adults
To achieve these objectives, the following outcomes are expected from grantee programs:
1. increased HIV testing among populations at risk for HIV
2. improved health care utilization among HIV infected adults and adolescents
This initiative has been undertaken by Kaiser to affect HIV at a population level via
community approaches to prevention, intervention and care in minority communities most
affected by HIV (e.g. gay, African American, and Latino communities). The University of
California, San Diego has developed and will oversee a cross-site evaluation of Kaiser
grantee programs funded under this initiative. Each site will have a treatment and comparison
group, and will conduct follow up surveys with their participants three and six months after
their interventions.
| Status | Completed |
| Enrollment | 583 |
| Est. completion date | December 2017 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Individuals will be adults, - aged 18 and over, - with the capacity to give informed consent. Exclusion Criteria: Those who do not have the capacity to give informed consent will be excluded. |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of California, San Diego, School of Medicine, Division of Global Public Health | La Jolla | California |
| Lead Sponsor | Collaborator |
|---|---|
| Kaiser Permanente | University of California, San Diego |
United States,
CDC, HIV/AIDS Surveillance Report. 2007; 19:7. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/pdf/2007SurveillanceRpoert.pdf
HIV Prevention Trials Network. Available at http://www.hptn.org/web%20documents/PressReleases/HPTN052PressReleaseFINAL5_12_118am.pdf.
Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009 Nov 15;49(10):1570-8. doi: 10.1086/644772. — View Citation
Ojikutu B, Johns Hopkins Advanced Studies in Medicine, Overcoming Challenges To Accessing and Adhering to Care in Minority Patients Living with HIV, 2010;2:37-41
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Increased HIV care utilization | Improved access to HIV care, particularly among newly diagnosed adults. | 3 and 6 months following intervention | |
| Secondary | Increased HIV testing among populations at risk for HIV | Increased HIV testing among populations at risk for HIV and identification of HIV infection among recently infected adults. | at baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |